Looks like you clickedhttps://www.globenewswire.com/news-release/2021/10/28/2322717/0/en/Candel-Therapeutics-Announces-Patient-Reported-Tolerability-Data-of-Intraprostatic-Injections-in-Ongoing-Phase-3-Clinical-Trial-of-CAN-2409-in-Patients-with-Localized-Prostate-Canc.html
If you do not want to visit that page, you can close this browser tab.
